Endogenous CRX expression and IRBP promoter activity in retinoblastoma cells

Brain Res. 2001 Oct 19;916(1-2):136-42. doi: 10.1016/s0006-8993(01)02884-0.

Abstract

Purpose: To determine whether antisense oligonucleotides (AODNs) targeted against CRX, a photoreceptor-specific trans-acting factor, suppress CRX expression and interphotoreceptor retinoid binding protein (IRBP) promoter activity.

Methods: Cultures of human retinoblastoma cells were transfected with chloramphenicol acetyltransferase (CAT) reporter plasmids containing a mouse IRBP promoter and AODNs directed against CRX. RT-PCR using primers specific to CRX, OTX2, GAPDH, or RNase H was conducted on total RNA isolated from retinoblastoma cells at various times following transfection with AODNs.

Results: Transfection of retinoblastoma cells with IRBP promoter CAT constructs alone produced high activity. Co-transfection with AODNs suppressed IRBP promoter activity in a concentration-dependent manner, with half-maximal effect produced at about 2 nM AODN concentration. Transfection with CAT constructs containing an SV40 promoter produced high activity that was unaffected by co-transfection with AODNs. RT-PCR products were obtained for all target sequences. CRX RT-PCR product from cells transfected with AODNs was greatly diminished following transfection with an AODN whereas control transcripts, including that of OTX2, were relatively unaffected.

Conclusions: The CRX-specific AODNs specifically and potently suppressed CRX expression and IRBP promoter activity, as measured by RT-PCR and transient transfection assays, respectively. Little or no effect was seen on controls. These data suggest that endogenous CRX is required for IRBP promoter activity in retinoblastoma cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence / genetics
  • Dose-Response Relationship, Drug
  • Eye Proteins*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Genes, Reporter / drug effects
  • Genes, Reporter / physiology
  • Genetic Vectors / physiology
  • Glyceraldehyde-3-Phosphate Dehydrogenases / drug effects
  • Glyceraldehyde-3-Phosphate Dehydrogenases / genetics
  • Homeodomain Proteins / drug effects*
  • Homeodomain Proteins / genetics
  • Humans
  • Molecular Sequence Data
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / genetics
  • Oligonucleotides, Antisense / pharmacology*
  • Otx Transcription Factors
  • Promoter Regions, Genetic / drug effects*
  • Promoter Regions, Genetic / physiology
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Retina / drug effects*
  • Retina / metabolism
  • Retinoblastoma
  • Retinol-Binding Proteins / drug effects*
  • Retinol-Binding Proteins / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Ribonuclease H / drug effects
  • Ribonuclease H / genetics
  • Trans-Activators / drug effects*
  • Trans-Activators / genetics
  • Transcription, Genetic / drug effects*
  • Transcription, Genetic / genetics
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism

Substances

  • Eye Proteins
  • Homeodomain Proteins
  • Nerve Tissue Proteins
  • OTX2 protein, human
  • Oligonucleotides, Antisense
  • Otx Transcription Factors
  • RNA, Messenger
  • Retinol-Binding Proteins
  • Trans-Activators
  • cone rod homeobox protein
  • interstitial retinol-binding protein
  • Glyceraldehyde-3-Phosphate Dehydrogenases
  • Ribonuclease H